Related references
Note: Only part of the references are listed.Annexin A1 drives macrophage skewing to accelerate muscle regeneration through AMPK activation
Simon McArthur et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Structure of formylpeptide receptor 2-Gi complex reveals insights into ligand recognition and signaling
Youwen Zhuang et al.
NATURE COMMUNICATIONS (2020)
Structural basis of ligand binding modes at the human formyl peptide receptor 2
Tong Chen et al.
NATURE COMMUNICATIONS (2020)
Dual modulation of formyl peptide receptor 2 by aspirin-triggered lipoxin contributes to its anti-inflammatory activity
Yunjun Ge et al.
FASEB JOURNAL (2020)
Discovery of BMS-986235/LAR-1219: A Potent Formyl Peptide Receptor 2 (FPR2) Selective Agonist for the Prevention of Heart Failure
Yoshikazu Asahina et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Balancing the Effect of Leukotrienes in Asthma
Catherine Godson
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Novel formyl peptide receptor (FPR) agonists with pyridinone and pyrimidindione scaffolds that are potentially useful for the treatment of rheumatoid arthritis
Letizia Crocetti et al.
BIOORGANIC CHEMISTRY (2020)
Formyl peptide receptor type 2 agonists to kick-start resolution pharmacology
Mauro Perretti et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Biased perspectives on formyl peptide receptors
Carsten Alexander Raabe et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2019)
Fpr2 Deficiency Alleviates Diet-Induced Insulin Resistance Through Reducing Body Weight Gain and Inhibiting Inflammation Mediated by Macrophage Chemotaxis and M1 Polarization
Xiaofang Chen et al.
DIABETES (2019)
The n-3 docosapentaenoic acid (DPA): A new player in the n-3 long chain polyunsaturated fatty acid family
Gaetan Drouin et al.
BIOCHIMIE (2019)
ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy
Simona Gallo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Substituted Pyridazin-3(2H)-ones as Highly Potent and Biased Formyl Peptide Receptor Agonists
Girdhar Singh Deora et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Annexin-A1: Therapeutic Potential in Microvascular Disease
Gareth S. D. Purvis et al.
FRONTIERS IN IMMUNOLOGY (2019)
Inhibition of FPR2 impaired leukocytes recruitment and elicited non resolving inflammation in acute heart failure
Vasundhara Kain et al.
PHARMACOLOGICAL RESEARCH (2019)
Asymmetric synthesis and biological evaluation of imidazole- and oxazole-containing synthetic lipoxin A4 mimetics (sLXms)
Monica de Gaetano et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration
Charles N. Serhan et al.
MOLECULAR ASPECTS OF MEDICINE (2018)
Targeting formyl peptide receptors to facilitate the resolution of inflammation
Janos G. Filep et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Cardioprotective signalling: Past, present and future
Aleksandar Jovanovic
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Formyl peptide receptor activation inhibits the expansion of effector T cells and synovial fibroblasts and attenuates joint injury in models of rheumatoid arthritis
Dragana Odobasic et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Neutrophils: Beneficial and Harmful Cells in Septic Arthritis
Daiane Boff et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Targeting Inflammation in the Prevention and Treatment of Type 2 Diabetes Insights From CANTOS
Subodh Verma et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Lipoxins Regulate the Early Growth Response-1 Network and Reverse Diabetic Kidney Disease
Eoin P. Brennan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
SPECIALIZED PRORESOLVING MEDIATORS IN INNATE AND ADAPTIVE IMMUNE RESPONSES IN AIRWAY DISEASES
Nandini Krishnamoorthy et al.
PHYSIOLOGICAL REVIEWS (2018)
Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury
Agostino Cilibrizzi
NATURE COMMUNICATIONS (2018)
Reply to 'Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury'
Cheng Xue Qin et al.
NATURE COMMUNICATIONS (2018)
Lipoxins Protect Against Inflammation in Diabetes-Associated Atherosclerosis
Eoin P. Brennan et al.
DIABETES (2018)
Specialized Pro-Resolving Lipid Mediators in Cystic Fibrosis
Reginald Philippe et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Mechanisms of signalling and biased agonism in G protein-coupled receptors
Denise Wootten et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Formyl-Peptide Receptors in Infection, Inflammation, and Cancer
Elisabeth Weiss et al.
TRENDS IN IMMUNOLOGY (2018)
(Re) Solving Repair After Myocardial Infarction
Giovanna Leoni et al.
FRONTIERS IN PHARMACOLOGY (2018)
Specialized Pro-resolving Lipid Mediators: Modulation of Diabetes-Associated Cardio-, Reno-, and Retino-Vascular Complications
Monica de Gaetano et al.
FRONTIERS IN PHARMACOLOGY (2018)
Biomarker-guided clinical development of the first-in-class anti-inflammatory FPR2/ALX agonist ACT-389949
Anna K. Stalder et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Synthesis of Five- and Six-Membered N-Phenylacetamido Substituted Heterocycles as Formyl Peptide Receptor Agonists
Claudia Vergelli et al.
DRUG DEVELOPMENT RESEARCH (2017)
Lipoxin A4 activates ALX/FPR2 receptor to regulate conjunctival goblet cell secretion
R. R. Hodges et al.
MUCOSAL IMMUNOLOGY (2017)
Inflammatory processes in cardiovascular disease: a route to targeted therapies
Neil Ruparelia et al.
NATURE REVIEWS CARDIOLOGY (2017)
Formyl Peptide Receptor 2 Is Involved in Cardiac Repair After Myocardial Infarction Through Mobilization of Circulating Angiogenic Cells
Soon Chul Heo et al.
STEM CELLS (2017)
Novel ureidopropanamide based N-formyl peptide receptor 2 (FPR2) agonists with potential application for central nervous system disorders characterized by neuroinflammation
Madia Letizia Stama et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Specialized pro-resolving mediators in renal fibrosis
Eoin P. Brennan et al.
MOLECULAR ASPECTS OF MEDICINE (2017)
The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition
Hui-Qiong He et al.
MOLECULES (2017)
Immune resolution mechanisms in inflammatory arthritis
Mauro Perretti et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The novel lipid mediator PD1n-3 DPA: An overview of the structural elucidation, synthesis, biosynthesis and bioactions
Trond Vidar Hansen et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2017)
Pilot application of lipoxin A4 analog and lipoxin A4 receptor agonist in asthmatic children with acute episodes
Xia Kong et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice
Cheng Xue Qin et al.
NATURE COMMUNICATIONS (2017)
FPR2 promotes invasion and metastasis of gastric cancer cells and predicts the prognosis of patients
Xi-Lu Hou et al.
SCIENTIFIC REPORTS (2017)
Biased G Protein-Coupled Receptor Signaling: New Player in Modulating Physiology and Pathology
Zuzana Bologna et al.
BIOMOLECULES & THERAPEUTICS (2017)
FPR2 signaling without β-arrestin recruitment alters the functional repertoire of neutrophils
Michael Gabl et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Functional N-Formyl Peptide Receptor2 (FPR2) Antagonists Based on the Ureidopropanamide Scaffold Have Potential To Protect Against Inflammation-Associated Oxidative Stress
Madia L. Stama et al.
CHEMMEDCHEM (2017)
Protective Effect of let-7 miRNA Family in Regulating Inflammation in Diabetes-Associated Atherosclerosis
Eoin Brennan et al.
DIABETES (2017)
The common promoter polymorphism rs11666254 downregulates FPR2/ALX expression and increases risk of sepsis in patients with severe trauma
Han Zhang et al.
CRITICAL CARE (2017)
Recent advances in the chemistry and biology of anti-inflammatory and specialized pro-resolving mediators biosynthesized from n-3 docosapentaenoic acid
Anders Vik et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists
Claudia Vergelli et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology
Brian E. Sansbury et al.
CIRCULATION RESEARCH (2016)
Structural modifications of the serotonin 5-HT7 receptor agonist N-(4-cyanophenylmethyl)-4-(2-biphenyl)-1-piperazinehexanamide (LP-211) to improve in vitro microsomal stability: A case study
Enza Lacivita et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation
Melody G. Duvall et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Lipoxin A4 augments host defense in sepsis and reduces Pseudomonas aeruginosa virulence through quorum sensing inhibition
Benedict Wu et al.
FASEB JOURNAL (2016)
Lipoxin A4 inhibits microglial activation and reduces neuroinflammation and neuropathic pain after spinal cord hemisection
Alessandra Cadete Martini et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Structure-based discovery of opioid analgesics with reduced side effects
Aashish Manglik et al.
NATURE (2016)
Resolution of inflammation: what Controls its Onset?
Michelle A. Sugimoto et al.
FRONTIERS IN IMMUNOLOGY (2016)
Specialized pro-resolving mediators: endogenous regulators of infection and inflammation
Maria C. Basil et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Novel translational model of resolving inflammation triggered by UV-killed E. coli
Madhur P. Motwani et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2016)
Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent
Sarah K. Orr et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease
Emma Boergeson et al.
CELL METABOLISM (2015)
Structural insights into μ-opioid receptor activation
Weijiao Huang et al.
NATURE (2015)
Resolution Pharmacology: Opportunities for Therapeutic Innovation in Inflammation
Mauro Perretti et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability
Marcelo H. Petri et al.
CARDIOVASCULAR RESEARCH (2015)
Cutting Edge: Maresin-1 Engages Regulatory T Cells To Limit Type 2 Innate Lymphoid Cell Activation and Promote Resolution of Lung Inflammation
Nandini Krishnamoorthy et al.
JOURNAL OF IMMUNOLOGY (2015)
FPR2/ALXR Agonists and the Resolution of Inflammation
Olivier Corminboeuf et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
A formyl peptide receptor agonist suppresses inflammation and bone damage in arthritis
W. Kao et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Reduced 15-lipoxygenase 2 and lipoxin A4/leukotriene B4 ratio in children with cystic fibrosis
Fiona C. Ringholz et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Structural Determinants for the Interaction of Formyl Peptide Receptor 2 with Peptide Ligands
Hui-Qiong He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Protective Actions of Aspirin-Triggered (17R) Resolvin D1 and Its Analogue, 17R-Hydroxy-19-Para-Fluorophenoxy-Resolvin D1 Methyl Ester, in C5a-Dependent IgG Immune Complex-Induced Inflammation and Lung Injury
Huifang Tang et al.
JOURNAL OF IMMUNOLOGY (2014)
Nonredundant protective properties of FPR2/ALX in polymicrobial murine sepsis
Thomas Gobbetti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The Resolvin D1 Analogue Controls Maturation of Dendritic Cells and Suppresses Alloimmunity in Corneal Transplantation
Jing Hua et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2014)
3-(1H-indol-3-yl)-2-[3-(4-nitrophenyl)ureido]propanamide enantiomers with human formyl-peptide receptor agonist activity: Molecular modeling of chiral recognition by FPR2
Igor A. Schepetkin et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Efficacy and safety of 15(R/S)-methyl-lipoxin A4 in topical treatment of infantile eczema
S-H Wu et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Cell Surface Receptor FPR2 Promotes Antitumor Host Defense by Limiting M2 Polarization of Macrophages
Ying Liu et al.
CANCER RESEARCH (2013)
Further studies on 2-arylacetamide pyridazin-3(2H)-ones: Design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists
Maria Paola Giovannoni et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Lipoxins Attenuate Renal Fibrosis by Inducing let-7c and Suppressing TGFβR1
Eoin P. Brennan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
OPINION Signalling bias in new drug discovery: detection, quantification and therapeutic impact
Terry Kenakin et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses
Sadani N. Cooray et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Lipoxin A4 Regulates Natural Killer Cell and Type 2 Innate Lymphoid Cell Activation in Asthma
Cindy Barnig et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Novel n-3 Immunoresolvents: Structures and Actions
Jesmond Dalli et al.
SCIENTIFIC REPORTS (2013)
The immune-stimulating peptide WKYMVm has therapeutic effects against ulcerative colitis
Sang Doo Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2013)
Leukocyte recruitment in the brain in sepsis: involvement of the annexin 1-FPR2/ALX anti-inflammatory system
Felicity N. E. Gavins et al.
FASEB JOURNAL (2012)
Specialized Proresolving Mediators Enhance Human B Cell Differentiation to Antibody-Secreting Cells
Sesquile Ramon et al.
JOURNAL OF IMMUNOLOGY (2012)
Resolvin E2 Formation and Impact in Inflammation Resolution
Sungwhan F. Oh et al.
JOURNAL OF IMMUNOLOGY (2012)
FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis
Paola Maderna et al.
FASEB JOURNAL (2010)
Resolvin D1 binds human phagocytes with evidence for proresolving receptors
Sriram Krishnamoorthy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Molecular Circuits of Resolution in Renal Disease
Emma Boergeson et al.
THESCIENTIFICWORLDJOURNAL (2010)
Are formyl peptide receptors novel targets for therapeutic intervention in ischaemia-reperfusion injury?
Felicity N. E. Gavins
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Lipoxins: resolutionary road
Paola Maderna et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Lipoxin A4: Anti-Inflammatory and Anti-Angiogenic Impact on Endothelial Cells
Nicole Baker et al.
JOURNAL OF IMMUNOLOGY (2009)
6-Methyl-2,4-Disubstituted Pyridazin-3(2H)-ones: A Novel Class of Small-Molecule Agonists for Formyl Peptide Receptors
Agostino Cilibrizzi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
R. D. Ye et al.
PHARMACOLOGICAL REVIEWS (2009)
Anti-inflammatory and pro-resolving properties of benzo-lipoxin A4 analogs
Yee-Ping Sun et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2009)
Design and synthesis of benzo-lipoxin A4 analogs with enhanced stability and potent anti-inflammatory properties
Nicos A. Petasis et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Genetic variation in members of the leukotriene biosynthesis pathway confer an increased risk of ischemic stroke - A replication study in two independent populations
Steve Bevan et al.
STROKE (2008)
Aromatic lipoxin A4 and lipoxin B4 analogues display potent biological activities
Timothy P. O'Sullivan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Pharmacological characterization of a novel nonpeptide antagonist for formyl peptide receptor-like 1
Caihong Zhou et al.
MOLECULAR PHARMACOLOGY (2007)
Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution
Eric L. Campbell et al.
FASEB JOURNAL (2007)
Resolvin E1 and protectin D1 activate inflammation-resolution programmes
Jan M. Schwab et al.
NATURE (2007)
The lipoxin A4 receptor is coupled to SHP-2 activation -: Implications for regulation of receptor tyrosine kinases
Derick Mitchell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation
Makoto Arita et al.
JOURNAL OF IMMUNOLOGY (2007)
Resolvin E2: Identification and anti-inflammatory actions: Pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis
Eric Tjonahen et al.
CHEMISTRY & BIOLOGY (2006)
Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents
Roland W. Burli et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Lipoxin A4 regulates bronchial epithelial cell responses to acid injury
C Bonnans et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
The lipoxin receptor ALX: Potent ligand-specific and stereoselective actions in vivo
Nan Chiang et al.
PHARMACOLOGICAL REVIEWS (2006)
Lipoxin A4 modifies platelet-derived growth factor-induced profibrotic gene expression in human renal mesangial cells
K Rodgers et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Second-generation beta-oxidation resistant 3-oxa-lipoxin A4 analogs
WJ Guilford et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2005)
Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1
M Arita et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway
CL Karp et al.
NATURE IMMUNOLOGY (2004)
Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration
G Bannenberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
A novel nonpeptide ligand for formyl peptide receptor-like 1
M Nanamori et al.
MOLECULAR PHARMACOLOGY (2004)
Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog
NE Kieran et al.
KIDNEY INTERNATIONAL (2003)
15-Epi-16-(para-fluorophenoxy)-lipoxin A4-methyl ester, a synthetic analogue of 15-epi-lipoxin A4, is protective in experimental ischemic acute renal failure
MO Leonard et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent
J Keane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins
IM Fierro et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2001)
Share Paper
